7499-73-2

Basic information

• Product Name: N-(4-bromo-2-nitronaphthalen-1-yl)acetamide
• CAS NO: 7499-73-2
• Molecular Formula: C₁₂H₉BrN₂O₃
• Molecular Weight: 309.1155
• Mol File: 7499-73-2.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 510°C at 760 mmHg
• Flash Point: 262.2°C
• Density: 1.674g/cm³
• Vapor Pressure: 1.61E-10mmHg at 25°C
• Refractive Index: 1.715
• CAS DataBase Reference: N-(4-bromo-2-nitronaphthalen-1-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-bromo-2-nitronaphthalen-1-yl)acetamide(7499-73-2)
• EPA Substance Registry System: N-(4-bromo-2-nitronaphthalen-1-yl)acetamide(7499-73-2)

Safety Data

• Hazardous Substances Data: 7499-73-2(Hazardous Substances Data)

Usage

General Description

N-(4-bromo-2-nitronaphthalen-1-yl)acetamide is a chemical compound with the molecular formula C12H9BrN2O3. It is a yellow to brown solid with the molecular weight of 299.12 g/mol. N-(4-bromo-2-nitronaphthalen-1-yl)acetamide is used in organic synthesis and can be utilized as a reagent or building block in the pharmaceutical and agrochemical industries. It is important to handle this chemical with caution as it may pose health and environmental hazards.

Upstream product

• 2437-30-1 N-(2-nitronaphthalen-1-yl)acetamide 
• 24402-72-0 N-(4-nitronaphthalen-1-yl)acetamide 
• 91394-66-0 1-(acetylamino)-4-bromonaphthalene 
• 861798-43-8 N-(4-bromo-5,8-dihydro-[1]naphthyl)-acetamide 
• 64-19-7 acetic acid 
• 7697-37-2 nitric acid 
• 32666-56-1 1-amino-5,8-dihydronaphthalene 
• 861294-59-9 N-(4,6,7-tribromo-5,6,7,8-tetrahydro-[1]naphthyl)-acetamide 
• 7664-93-9 sulfuric acid 
• 575-36-0 1-acetamidonaphthalene 
• 2298-07-9 4-Bromo-1-naphthylamine 
• 108-24-7 acetic anhydride 

Downstream Products

• 62148-28-1 5-bromo-2-methyl-1⁽³⁾H-naphtho[1,2-d]imidazole 
• 90767-01-4 4-bromo-2-nitro-1-naphthylamine 
• 905302-18-3 4-bromo-2-nitro-[1]naphthol 
• 33670-68-7 4-bromo-1-diazonio-naphthalen-2-olate 
• 759398-90-8 4-bromo-1-chloro-[2]naphthylamine 
• 51670-69-0 N-(4-bromo-1-chloro-[2]naphthyl)-acetamide 
• 52289-50-6 1,4-dibromo-2-nitro-naphthalene 
• 858024-98-3 N,N'-(4-bromo-naphthalene-1,2-diyl)-bis-acetamide 
• 7499-65-2 4-bromo-2-nitronaphthalene 
• 74924-94-0 4-bromonaphthalene-2-amine 
• 1578179-15-3 2-(4-iodonaphthalen-2-ylamino)-5-nitrobenzoic acid 
• 1071083-21-0 4-bromo-1-iodo-2-nitronaphthalene 
• 102170-75-2 4,4'-dibromo-2,2'-dinitro-[1,1']binaphthyl 

Relevant articles and documents

KRAS G12D INHIBITORS

The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.

METHODS AND FORMULATIONS TO TREAT MITOCHONDRIAL DYSFUNCTION

Methods of treatment and pharmaceutical formulations configured to treat primary and secondary mitochondrial dysfunction are provided. The methods and treatments use an agonist of AMPK. The agonist activates AMPK to activate ATP-producing pathways and inhibiting ATP-consuming pathways, thus allowing for the alleviation of symptoms associated with mitochondrial dysfunctions.

Novel compound and organic light emitting device comprising the same

The present invention provides a novel compound containing amino groups at both ends of a molecule and an organic light emitting device having the novel compound. The present invention also provides the organic light emitting device comprising: a first electrode; a second electrode facing the first electrode; and at least one organic material layer provided between the first electrode and the second electrode.COPYRIGHT KIPO 2019